A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation

NCT04417569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-02-18

No results posted yet for this study

Summary

This study will determine the rise of progesterone levels after human chorionic gonadotrophin (hCG) trigger in stimulated cycles IVF/ICSI

Conditions

Interventions

DRUG

hCG

human chorionic gonadotropin

DIAGNOSTIC_TEST

Ultrasound

Endometrial thickness monitoring

OTHER

Blood test

Progesterone, Luteinizing Hormone, Estradiol

Sponsors & Collaborators

  • ART Fertility Clinics LLC

    lead OTHER

Principal Investigators

  • Raquel Loja Vitorino, Specialist · ART Fertility Clinics LLC

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-04
Primary Completion
2021-05-26
Completion
2021-06-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04417569 on ClinicalTrials.gov